The abstract is read at the publisher; the summary is JClub's.
A 3-day doxycycline induction of inducible BMP2-lentivirus in CG cellularized cryogel scaffolds eliminates heterotopic ossification while still promoting near-complete bone bridging in a mouse femoral nonunion model.
- Why it matters: Nonunions affect 5–10% of fracture patients, and existing therapies are costly with variable success, motivating localized, controllable BMP2 delivery to improve healing outcomes.
- What they did: Tube-shaped chitosan-gelatin (CG) and chitosan-agarose-gelatin (CAG) cryogels delivered doxycycline-inducible BMP2-lentivirus (BMP2-LV), either acellular or seeded with adipose-derived stem cells (BMP2-LV-ASC), and were tested in mice with continuous or 3-day doxycycline dosing.
- The result: With continuous doxycycline, BMP2-expressing scaffolds increased callus mineralization at 2 weeks and achieved near-complete bridging by 8 weeks, but CG/CAG BMP2-LV-ASC also caused heterotopic ossification; restricting doxycycline to the first 3 days eliminated it by 8 weeks.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.